 |
N.B. Unless otherwise stated in the footnotes below, each coloured box represents one dose of MenC vaccine. |
|
(1) |
The MenC vaccine is recommended simultaneously with the booster dose of the DTaP-HBV-IPV- Hib hexavalent vaccine at 13-18 months of age (preferably at 15 months of age)
. |
(2) |
MenC is given universally by the private sector while the public sector targets selected groups with e.g. sickle cell disease, immune deficiency etc. |
(3) |
One dose in the 2nd year of life; should not be administered simultaneously with MMR + monovalent Varicella vaccine or MMRV vaccine. |
(4) |
If vaccination starts at the age of >12 months, only 1 dose is recommended. |
(5) |
Vaccination with conjugated Meningococcal vaccine was introduced in the childhood vaccination schedule in October 2002 together with a vaccination campaign to include children 6 months-19 years. |
(6) |
A single dose of MenC vaccine is given for those 12 months to 22 years who have not received the routine 3 doses in infancy. |
(7) |
Meningococcal C conjugate vaccine is recommended at national level for selected groups only. |
(8) |
The third MenC dose is given around 12 months of age with Hib as a combined vaccine. |
|
This overview is derived from national childhood vaccination schedules as provided to EUVAC.NET. More information is obtained from individual national schedules.
|
|
